TMRW Vault® Achieves CE Marking as Class IIa Medical Device in Europe

TMRW Vault® Achieves CE Marking for Medical Device Compliance

In a significant advancement for reproductive health technology, Reprotech has announced that its innovative product, the TMRW Vault®, has been awarded CE marking as a Class IIa medical device under the EU Medical Device Regulation (MDR) 2017/745. This certification is a crucial milestone that paves the way for the TMRW Vault® to be marketed not only within the European Union but also in various international markets that recognize CE certification.

The Significance of CE Marking

The CE marking on the TMRW Vault® signifies that the device meets stringent European health, safety, and environmental protection standards. For Reprotech, this achievement not only boosts its credibility as a leader in the fertility sector but also enhances the accessibility of advanced reproductive solutions to fertility clinics across Europe.

What is the TMRW Vault®?

The TMRW Vault® is more than just a cryogenic freezer; it represents a technological leap in sperm, oocyte, and embryo storage. It combines advanced digital tracking capabilities with scalable cryo-storage solutions to mitigate risks associated with manual storage systems while enhancing sample traceability.

Clinics often face the daunting task of managing rising volumes of cryogenically preserved tissue from reproductive procedures. Traditional storage methods are typically manual, leading to operational inefficiencies and a higher risk of human error. The TMRW Vault® addresses these issues by integrating a cutting-edge physical infrastructure with an exclusive software platform known as ivfOS®, designed to create a robust digital solution that ensures continuous monitoring, real-time inventory management, and secure sample traceability.

Key Features of the TMRW Vault®

1. Digital Sample Management: Equipped with CryoBeacons utilizing RFID technology, the TMRW Vault® ensures digital verification of sample identity and location.
2. Automated Access: It allows embryologists to efficiently store and retrieve samples while guaranteeing complete digital traceability.
3. Advanced Monitoring: Through TMRW Overwatch®, the system conducts thousands of daily checks, overseen by specialists, to maintain optimal storage conditions.
4. Scalable Storage Capacity: Occupying just one-third of the floor space, a single Vault can hold up to ten standard Dewar flasks.
5. Seamless Integration: The Vault® integrates effortlessly with the entire TMRW ecosystem and off-site cryo-storage services,
6. Quick Installation: Clinics can quickly set up the system, minimizing disruption to their operations.

A Stronger Future for Reproductive Health

This announcement follows the merger of Reprotech and TMRW Life Sciences in April 2026, creating a powerhouse that brings decades of cryostorage expertise together with next-generation sample management technologies. The acquisition of IMT Matcher in June 2025 further solidified this entity's position as a comprehensive provider for fertility centers, offering solutions that span sample verification, digital traceability, onsite and offsite cryostorage, consent management, and billing administration.

Reprotech, as the foremost provider of products and services dedicated to the long-term preservation and management of reproductive tissue samples, reinforces its commitment to ensuring high standards of safety and efficiency. With a robust portfolio that includes seven specialized biobanks and state-of-the-art cryostorage technologies, Reprotech aims to simplify processes, reduce risks, and safeguard samples throughout their lifecycle.

As the demand for fertility solutions continues to rise, innovations like the TMRW Vault® are not just timely; they are vital to improving outcomes and ensuring that essential reproductive resources are preserved securely and efficiently.

Visit the official website at www.reprotech.com for more details.